insights_auto
Why is HLI up 3.69%?
Dive Deeperchevron_right
HLI:NYSE
Houlihan Lokey Inc
$130.16
arrow_upward
+3.69%(+4.63) 1D
$130.16
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 9, 4:00:06 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLI...
Open
$128.79
High
$130.88
Low
$126.40
Mkt. cap
9.10B
Avg. vol.
834.11K
Volume
913.57K
Dividend
2.15%
Quarterly dividend
$0.70
Ex-dividend date
Sep 1, 2026
P/E ratio
21.83
52-wk high
$204.18
52-wk low
$112.83
EPS
$5.96
Beta
1.00
Shares outstanding
54.20M
No. of employees
3K
Open
$128.79
High
$130.88
Low
$126.40
Mkt. cap
9.10B
Avg. vol.
834.11K
Volume
913.57K
Dividend
2.15%
Quarterly dividend
$0.70
Ex-dividend date
Sep 1, 2026
P/E ratio
21.83
52-wk high
$204.18
52-wk low
$112.83
EPS
$5.96
Beta
1.00
Shares outstanding
54.20M
No. of employees
3K
News stories
From web sources and news partners
StockStory
·
1 day ago
Houlihan Lokey (HLI) Stock Is Up, What You Need To Know
Profile
Houlihan Lokey, Inc. is an American multinational independent investment bank and financial services company, and the No. 1 ranked global M&A advisor by transaction count. Houlihan Lokey was founded in 1972 and is headquartered at Constellation Place in Century City, Los Angeles, California.
The firm advises large public and closely held companies as well as institutions and governments. Its main service lines include mergers and acquisitions, capital solutions, restructuring and distressed M&A, fairness opinions, and financial and valuation advisory. As of February 2026, Houlihan Lokey employs more than 2,700 employees worldwide. Wikipedia
About Houlihan Lokey Inc
CEOScott Adelson
Employees2.8K
Founded1972
HeadquartersLos Angeles, California, United States
SectorCapital market
Websitehl.com
Analyst ratings
Based on 9 analysts giving stock ratings to HLI in the past 3 months
Buy
Buy
6
Hold
3
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for HLI in the last 3 months.
Highest
Current $130.16
$175.00 (+34.45%)
Average
$156.14 (+19.96%)
Lowest
$147.00 (+12.94%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Devin Ryan Citizens JMP | Buy | Upgraded | $175.00 | +34.4% | 10/09/2026 |
Ryan Kenny Morgan Stanley | Buy | Maintained | $165.00 | +26.8% | 10/08/2026 |
Alex Bond KBW | Buy | Maintained | $150.00 | +15.2% | 10/08/2026 |
Michael Brown UBS | Hold | Maintained | $154.00 | +18.3% | 10/06/2026 |
Brennan Hawken BMO Capital | Buy | Maintained | $150.00 | +15.2% | 10/06/2026 |
James Yaro Goldman Sachs | Buy | Maintained | $152.00 | +16.8% | 09/09/2026 |
Ken Worthington J.P. Morgan | Hold | Maintained | $147.00 | +12.9% | 08/04/2026 |
Gabriel Angelini Bank of America Securities | Buy | Maintained | - | - | 07/31/2026 |
Unknown Analyst Seaport Global | Hold | Maintained | - | - | 07/30/2026 |
Ebrahim Poonawala Bank of America Securities | Buy | Initiated | $164.00 | +26% | 07/10/2026 |
Unknown Analyst Bank of America Securities | Buy | Initiated | $164.00 | +26% | 07/10/2026 |
Last report
Jul 29, 2026
Fiscal period
Q1 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$1.35 / $1.64
-17.69%miss
arrow_downward
Revenue / Est. (USD)
511.00M / 599.29M
-14.73%miss
arrow_downward
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 659.45M | 717.07M | 635.64M | 511.00M |
Cost of goods sold | 31.87M | 39.09M | 39.84M | 38.00M |
Cost of revenue | 31.87M | 39.09M | 39.84M | 38.00M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 433.63M | 472.26M | 426.64M | 352.00M |
Operating expense | 458.60M | 499.68M | 452.80M | 379.00M |
Total operating expenses | 490.47M | 538.77M | 492.63M | 417.00M |
Operating income | 168.98M | 178.30M | 143.01M | 94.00M |
Other non operating income | 8.71M | 8.92M | 27.26M | 8.00M |
EBT including unusual items | 160.05M | 169.65M | 134.51M | 86.00M |
EBT excluding unusual items | 177.69M | 187.22M | 170.27M | 100.00M |
Income tax expense | 48.27M | 53.10M | 36.20M | 8.00M |
Effective tax rate | 30.16% | 31.30% | 26.91% | 9.30% |
Other operating expenses | 14.66M | 19.12M | 18.12M | 19.00M |
Net income | 111.78M | 116.55M | 99.84M | 78.00M |
Net profit margin | 16.95% | 16.25% | 15.71% | 15.26% |
Earnings per share | 1.84 | 1.94 | 1.63 | 1.35 |
Interest and investment income | - | - | - | - |
Interest expense | - | - | - | - |
Net interest expenses | - | - | - | - |
Depreciation and amortization charges | 10.30M | 8.30M | 8.04M | 8.00M |
EBITDA | - | - | - | - |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1